ArticleJournal of medicinal chemistry2026
Late-Stage Functionalization via Thianthrenation: A Reaction Enabling Rapid Preparation of Drug Beads for Chemical Pulldown.
Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
A major bottleneck in identifying the molecular targets of phenotypically active compounds via affinity pulldown is the chemical synthesis of functionalized probes suitable for attachment to solid supports. This process often requires time-intensive, multistep synthesis. A more direct approach would be to use late-stage functionalization chemistry to directly modify the phenotypic hit/lead. We report a proof-of-concept workflow adapting the thianthrenation late-stage functionalization reaction to expedite the preparation of probes. A high-throughput experimental approach allowed rapid assessment of substrate suitability for this chemical reaction. Twenty-four compounds with activity against the protozoan parasite Leishmania donovani were progressed through this workflow. Five compounds were identified as thianthrenation substrates, and four were functionalized to prepare affinity probes. Compound 9b was advanced to target identification in L. donovani, with molecular targets identified with high confidence. These studies highlight the utility of late-stage functionalization reactions to expedite the synthesis of functionalized tool compounds for multiple downstream applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.